 BioNTech doubled third-quarter profit expectations Monday and raised its full-year outlook for Covid vaccine sales but BNTX stock toppled. The post BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 Outlook appeared first on Investors Business Daily. 